News
Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...
At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, the Eye Care Network caught up with Jogin ...
Hamby and Lizama, shows zervimesine may protect retinal cells from the onslaught ... concept clinical trial in 100 people with geographic atrophy secondary to dry AMD, treatment with zervimesine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results